Correct use of EIKANCE 0.01% atropine sulfate eye drops and medication guidance for children and adults

0.01% Atropine Sulfate Eye Drops (EIKANCE) is a low-concentration atropine eye drop, mainly used to control the progression of myopia in children, and can also be used for adult ophthalmic treatment under certain circumstances. Its pharmacological effect is mainly through mild pupil dilation and ciliary muscle adjustment, slowing down the growth of the eye axis, thereby delaying the development of myopia. EIKANCEAs a low-concentration atropine preparation, compared with traditional high-concentration eye drops, the incidence of adverse reactions is lower, but the dosage and usage specifications still need to be strictly followed to ensure efficacy and safety.

In terms of myopia prevention and control in children, EIKANCE usually follows a once-daily eye drop regimen. It is recommended to use it at night before going to bed, instilling one drop of 0.01% Atropine Sulfate Eye Drops into each eye at a time. Medication for children must be carried out under the guidance of parents or guardians to prevent children from operating it on their own. Before applying eye drops, you should wash your hands and keep your eyes clean to prevent infection or contamination of eye drops. When using, avoid contacting eyelids or eyelash tips with eye drops to maintain sterility of the solution. After eye drops, you can gently close your eyes for 1-2 minutes to help the cornea and conjunctiva be fully covered by the medicine.

For adult use, EIKANCE's dosing instructions are similar to those for children, but it is usually used clinically to control axial growth or relieve specific ocular accommodation problems. Adult users should follow the doctor's prescription or guidance, instill one drop at a time, once a day or adjust the frequency according to individual conditions. For adults with higher requirements for fine vision in their careers or lives, it is important to note that low concentrations of atropine may still cause slight astigmatism or pupil dilation. It is recommended to observe visual adaptation in the early stages of use and avoid driving at night or operating precision instruments.

In terms of long-term medication management, both children and adults should undergo regular eye examinations, including visual acuity testing, axial measurement, and intraocular pressure assessment. Children in particular need follow-up every 3 to 6 months to assess myopia progression and drug efficacy. If significant eye discomfort, allergic reaction, or sudden change in vision occurs, stop taking the medication and seek medical advice immediately. In addition, it is usually recommended to use the medicinal solution within a specified time after opening, and avoid long-term storage to prevent the efficacy from decreasing or contamination. In short, 0.01%Atropine Sulfate Eye Drops (EIKANCE) can safely and effectively play a role in controlling myopia while taking into account the safety and visual health of children and adults, provided that the usage method and regular monitoring are strictly followed.

Keyword tags: Atropine sulfate eye drops, usage guide, children's myopia, adult medication, EIKANCE, myopia control, side effects, ophthalmological review.

Reference materials:https://pubmed.ncbi.nlm.nih.gov/?term=atropine+eye+drops